| scholarly article | Q13442814 |
| P50 | author | Peter Carmeliet | Q2074300 |
| P2093 | author name string | Michael Simons | |
| Masahiro Murakami | |||
| Radu V Stan | |||
| Zhen W Zhuang | |||
| Loc T Nguyen | |||
| Karen L Moodie | |||
| P2860 | cites work | Cellular signaling by fibroblast growth factor receptors | Q24301087 |
| Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2 | Q24313613 | ||
| Receptor specificity of the fibroblast growth factor family | Q24320178 | ||
| Fibroblast growth factors | Q24542507 | ||
| A core function for p120-catenin in cadherin turnover | Q24672238 | ||
| A novel role for p120 catenin in E-cadherin function | Q24674430 | ||
| Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family | Q24676527 | ||
| Fibroblast growth factors are required for efficient tumor angiogenesis | Q56787224 | ||
| Comparative Evaluation of FGF-2–, VEGF-A–, and VEGF-C–Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability | Q57382107 | ||
| Angiogenesis-Dependent and Independent Phases of Intimal Hyperplasia | Q59703772 | ||
| Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo | Q64377981 | ||
| Male-to-female sex reversal in mice lacking fibroblast growth factor 9 | Q73719496 | ||
| A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor | Q78423901 | ||
| Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity | Q80065659 | ||
| PKCalpha activates eNOS and increases arterial blood flow in vivo | Q81009178 | ||
| VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin | Q28116308 | ||
| Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis | Q28140788 | ||
| Deleted in colorectal carcinoma (DCC) binds heparin via its fifth fibronectin type III domain | Q28252122 | ||
| Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells | Q28255242 | ||
| VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly | Q28298669 | ||
| Requirement of FGF-4 for postimplantation mouse development | Q28304838 | ||
| Fibroblast growth factor signaling during early vertebrate development | Q28305654 | ||
| N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis | Q28505270 | ||
| Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development | Q28511544 | ||
| Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo | Q28584770 | ||
| Association of Csk to VE-cadherin and inhibition of cell proliferation | Q28591299 | ||
| Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme | Q28594173 | ||
| Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. | Q33787009 | ||
| Adipose tissue mass can be regulated through the vasculature | Q34075818 | ||
| p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin | Q34099519 | ||
| The role of FGF and VEGF in angioblast induction and migration during vascular development | Q34123470 | ||
| Endothelial cell-cell junctions: happy together | Q35741007 | ||
| Protecting your tail: regulation of cadherin degradation by p120-catenin | Q35885630 | ||
| Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis | Q36111400 | ||
| Fibroblast growth factor signaling in tumorigenesis | Q36111404 | ||
| Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin | Q36213628 | ||
| Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo | Q36435638 | ||
| Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors | Q36670394 | ||
| Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration | Q40032461 | ||
| p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. | Q40203974 | ||
| Signals via FGF receptor 2 regulate migration of endothelial cells | Q40764999 | ||
| A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor | Q41082296 | ||
| VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation | Q41672985 | ||
| Specific phosphorylation of p120-catenin regulatory domain differently modulates its binding to RhoA. | Q41998654 | ||
| N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken | Q42490043 | ||
| Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms | Q42839233 | ||
| Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. | Q44132458 | ||
| Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. | Q46008404 | ||
| Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state | Q46096039 | ||
| Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling | Q46158906 | ||
| VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature | Q46231250 | ||
| Pathophysiological consequences of VEGF-induced vascular permeability | Q46349878 | ||
| Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. | Q47977873 | ||
| Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. | Q51804915 | ||
| Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration. | Q52570697 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3355-3366 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The FGF system has a key role in regulating vascular integrity | |
| P478 | volume | 118 |
| Q42649977 | "On-target" cardiac effects of anticancer drugs: lessons from new biology |
| Q90321028 | A Combined Proteomics and Bioinformatics Approach Reveals Novel Signaling Pathways and Molecular Targets After Intracerebral Hemorrhage |
| Q35156024 | A method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNA |
| Q41637016 | Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover |
| Q37327475 | Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung |
| Q35084192 | Allosteric regulation of pathologic angiogenesis: potential application for angiogenesis-related blindness |
| Q34319305 | An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension |
| Q39368829 | Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. |
| Q38191586 | Antiangiogenesis therapy: an update after the first decade |
| Q30496270 | Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis |
| Q51454835 | Aqueous humour concentrations of TGF-β, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy. |
| Q49646426 | Arterial Thickness and Stiffness Are Independently Associated with Left Ventricular Strain |
| Q63258845 | Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients |
| Q90910800 | Autophagy regulates the therapeutic potential of adipose-derived stem cells in LPS-induced pulmonary microvascular barrier damage |
| Q39084965 | Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function |
| Q37342215 | Breaking the VE-cadherin bonds. |
| Q38953727 | Cadherin tales: Regulation of cadherin function by endocytic membrane trafficking |
| Q30546913 | Cardiomyocyte FGF signaling is required for Cx43 phosphorylation and cardiac gap junction maintenance |
| Q35643192 | Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae |
| Q50760843 | Cellular and molecular regulation of vascular permeability. |
| Q51925608 | Cis-regulation and chromosomal rearrangement of the fgf8 locus after the teleost/tetrapod split. |
| Q35801052 | Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors |
| Q26823757 | Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin) |
| Q92043470 | Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins |
| Q64095112 | Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice |
| Q37581139 | Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II. |
| Q46564265 | Distinct bone marrow blood vessels differentially regulate haematopoiesis. |
| Q34348632 | Embryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells. |
| Q92732372 | Endothelial ERK1/2 signaling maintains integrity of the quiescent endothelium |
| Q54406233 | Endothelial FGF receptor signaling accelerates atherosclerosis |
| Q47725044 | Endothelial Glycocalyx Repair: Building a Wall to Protect the Lung during Sepsis |
| Q88639628 | Endothelial Metabolic Control of Lymphangiogenesis |
| Q34218313 | Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. |
| Q87107041 | Endothelial permeability and VE-cadherin: a wacky comradeship |
| Q33728179 | Endothelial permeability and VE-cadherin: a wacky comradeship. |
| Q92323965 | Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases |
| Q45065946 | Essential Role of IL-12 in Angiogenesis in Type 2 Diabetes |
| Q40046898 | Examining the Role of Sphingosine Kinase-2 in the Regulation of Endothelial Cell Barrier Integrity. |
| Q41466827 | Expression of pro- and anti-angiogenic factors during the formation of the periocular vasculature and development of the avian cornea |
| Q41933095 | FGF receptor antagonism does not affect adipose tissue development in nutritionally induced obesity |
| Q36501648 | FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression |
| Q41979549 | FGF signaling preserves the integrity of endothelial adherens junctions |
| Q43076661 | FGF-dependent metabolic control of vascular development |
| Q35572401 | FGF-dependent regulation of VEGF receptor 2 expression in mice |
| Q59804731 | FGF10 Signaling in Heart Development, Homeostasis, Disease and Repair |
| Q92002839 | FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD) |
| Q38644648 | FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway |
| Q91026839 | FRS2α-dependent cell fate transition during endocardial cushion morphogenesis |
| Q54320094 | Fibroblast growth factor receptor 1 is a key inhibitor of TGFβ signaling in the endothelium. |
| Q42448836 | Fibroblast growth factor receptor two (FGFR2) regulates uterine epithelial integrity and fertility in mice. |
| Q33751715 | Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis |
| Q27011668 | Fibroblast growth factor signaling in the vasculature |
| Q34282040 | Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2 |
| Q37284160 | Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice |
| Q42587804 | Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice. |
| Q30487913 | Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart |
| Q38152380 | Glial influence on the blood brain barrier. |
| Q38561270 | Glial regulation of the blood-brain barrier in health and disease. |
| Q34341522 | Harnessing developmental processes for vascular engineering and regeneration |
| Q36071299 | Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells |
| Q35542968 | Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells. |
| Q47727030 | IGF-1 promotes angiogenesis in endothelial cells/adipose-derived stem cells co-culture system with activation of PI3K/Akt signal pathway. |
| Q28388381 | Immature endothelial cells initiate endothelin-mediated constriction of newborn arteries |
| Q39501414 | Immortalization of swine umbilical vein endothelial cells (SUVECs) with the simian virus 40 large-T antigen |
| Q46358618 | Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries |
| Q39193273 | In Development-A New Paradigm for Understanding Vascular Disease |
| Q83259315 | Insights into defibrotide as therapy for veno-occlusive disease |
| Q37054315 | Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system |
| Q34135320 | Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC |
| Q58803336 | Knockdown of the KINDLIN-2 Gene and Reduced Expression of Kindlin-2 Affects Vascular Permeability in Angiogenesis in a Mouse Model of Wound Healing |
| Q35201970 | Live cell imaging of primary rat neonatal cardiomyocytes following adenoviral and lentiviral transduction using confocal spinning disk microscopy |
| Q57817458 | Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 |
| Q41437410 | Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. |
| Q38422834 | Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow |
| Q38065844 | Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs): potential role in healing cutaneous chronic wounds |
| Q55295930 | Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a. |
| Q48243816 | Microfluidic Tumor-Vascular Model to Study Breast Cancer Cell Invasion and Intravasation. |
| Q29547314 | Molecular mechanisms and clinical applications of angiogenesis |
| Q41762927 | Need glucose to sprout: local metabolic control of angiogenesis |
| Q35539061 | Nuclear signaling from cadherin adhesion complexes |
| Q84897016 | Nutritional supplementation with L-arginine prevents pelvic radiation-induced changes in morphology, density, and regulating factors of blood vessels in the wall of rat bladder |
| Q38748690 | Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis |
| Q37267378 | PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting |
| Q39305373 | Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients |
| Q37053858 | Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease |
| Q30497938 | Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation |
| Q41473205 | Pigment epithelium-derived factor regulates microvascular permeability through adipose triglyceride lipase in sepsis |
| Q37582394 | Potential application of mesenchymal stem cells in acute lung injury |
| Q28387256 | Pressure-induced maturation of endothelial cells on newborn mouse carotid arteries |
| Q64095865 | Pro-angiogenic Ginsenosides F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 |
| Q30575663 | Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2 (FGF2)-induced osteoblast differentiation |
| Q38984566 | RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function. |
| Q38219954 | Receptor tyrosine kinases endocytosis in endothelium: biology and signaling |
| Q26778080 | Regulation of Endothelial Adherens Junctions by Tyrosine Phosphorylation |
| Q37428915 | Regulation of vascular integrity. |
| Q54487345 | Role of fibroblast growth factor signaling in vascular formation and maintenance: orchestrating signaling networks as an integrated system. |
| Q27025540 | Roles of FGF signaling in stem cell self-renewal, senescence and aging |
| Q90744888 | SENCR stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4 |
| Q39333626 | Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation |
| Q39752032 | Signaling required for blood vessel maintenance: molecular basis and pathological manifestations |
| Q35702052 | Significance of the antiangiogenic mechanisms of thalidomide in the therapy of diabetic retinopathy |
| Q36776815 | Specialized tip/stalk-like and phalanx-like endothelial cells from embryonic stem cells |
| Q52632502 | Sprouty2 expression controls endothelial monolayer integrity and quiescence. |
| Q37308214 | Syndecan 4 regulates FGFR1 signaling in endothelial cells by directing macropinocytosis |
| Q34467171 | The Fibroblast Growth Factor signaling pathway |
| Q41871394 | The bipartite rac1 Guanine nucleotide exchange factor engulfment and cell motility 1/dedicator of cytokinesis 180 (elmo1/dock180) protects endothelial cells from apoptosis in blood vessel development. |
| Q34931170 | The blood-brain barrier |
| Q35826679 | The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling |
| Q41717437 | The expression and function of miR-424 in infantile skin hemangioma and its mechanism |
| Q39127982 | The molecular basis of endothelial cell plasticity. |
| Q43832117 | The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. |
| Q64106024 | The therapeutic effects of bone marrow-derived mesenchymal stromal cells in the acute lung injury induced by sulfur mustard |
| Q27023731 | Therapeutic angiogenesis: controlled delivery of angiogenic factors |
| Q42227655 | Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes |
| Q28246124 | Thrombin and vascular inflammation |
| Q37743207 | Tumor angiogenesis: insights and innovations |
| Q42141595 | VE-Cadherin Disassembly and Cell Contractility in the Endothelium are Necessary for Barrier Disruption Induced by Tumor Cells |
| Q37393447 | VE-cadherin involved in the pulmonary microvascular endothelial cell barrier injury induced by angiotensin II through modulating the cellular apoptosis and skeletal rearrangement |
| Q37779858 | VE-cadherin: at the front, center, and sides of endothelial cell organization and function |
| Q89747820 | VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration |
| Q41728173 | Vascular Aging: Implications for Cardiovascular Disease and Therapy. |
| Q50277380 | Vascular endothelial growth factor confers endothelial resistance to apoptosis through poly(ADP-ribose) polymerase. |
| Q38130686 | Vascular permeability and drug delivery in cancers |
| Q34972793 | Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials |
| Q35633027 | When it is better to regress: dynamics of vascular pruning. |
| Q33917585 | bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain Injury |
Search more.